Allakos Management

Management criteria checks 3/4

Allakos' CEO is Robert Alexander, appointed in Apr 2017, has a tenure of 7.67 years. total yearly compensation is $6.30M, comprised of 12.8% salary and 87.2% bonuses, including company stock and options. directly owns 0.83% of the company’s shares, worth €855.36K. The average tenure of the management team and the board of directors is 3.7 years and 6.5 years respectively.

Key information

Robert Alexander

Chief executive officer

US$6.3m

Total compensation

CEO salary percentage12.8%
CEO tenure7.7yrs
CEO ownership0.8%
Management average tenure3.7yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Robert Alexander's remuneration changed compared to Allakos's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$179m

Jun 30 2024n/an/a

-US$206m

Mar 31 2024n/an/a

-US$214m

Dec 31 2023US$6mUS$805k

-US$186m

Sep 30 2023n/an/a

-US$166m

Jun 30 2023n/an/a

-US$151m

Mar 31 2023n/an/a

-US$165m

Dec 31 2022US$7mUS$782k

-US$320m

Sep 30 2022n/an/a

-US$371m

Jun 30 2022n/an/a

-US$403m

Mar 31 2022n/an/a

-US$411m

Dec 31 2021US$11mUS$745k

-US$270m

Sep 30 2021n/an/a

-US$220m

Jun 30 2021n/an/a

-US$199m

Mar 31 2021n/an/a

-US$181m

Dec 31 2020US$14mUS$710k

-US$153m

Sep 30 2020n/an/a

-US$134m

Jun 30 2020n/an/a

-US$113m

Mar 31 2020n/an/a

-US$93m

Dec 31 2019US$13mUS$600k

-US$85m

Sep 30 2019n/an/a

-US$75m

Jun 30 2019n/an/a

-US$65m

Mar 31 2019n/an/a

-US$55m

Dec 31 2018US$8mUS$500k

-US$44m

Sep 30 2018n/an/a

-US$37m

Jun 30 2018n/an/a

-US$32m

Mar 31 2018n/an/a

-US$27m

Dec 31 2017US$1mUS$300k

-US$24m

Compensation vs Market: Robert's total compensation ($USD6.30M) is above average for companies of similar size in the German market ($USD469.36K).

Compensation vs Earnings: Robert's compensation has been consistent with company performance over the past year.


CEO

Robert Alexander (54 yo)

7.7yrs

Tenure

US$6,299,426

Compensation

Dr. Robert Alexander, Ph D., had been an Independent Director of Allena Pharmaceuticals, Inc. since June 2016 until 2022. He has been the Chief Executive Officer of Allakos Inc. since April 2017 and served...


Leadership Team

NamePositionTenureCompensationOwnership
Robert Alexander
CEO & Director7.7yrsUS$6.30m0.83%
€ 855.4k
Adam Tomasi
President5.3yrsUS$4.27m0.37%
€ 377.4k
Baird Radford
Chief Financial Officer3.7yrsUS$2.74mno data
Mary Cromwell
Chief Technical Officer1.4yrsno datano data
Chin Lee
Chief Medical Officerless than a yearno data0.31%
€ 317.1k
Alan Chang
Director of Medical Affairs & Data Analyticsno datano datano data

3.7yrs

Average Tenure

54yo

Average Age

Experienced Management: 37Z's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Robert Alexander
CEO & Director7.6yrsUS$6.30m0.83%
€ 855.4k
Paul Walker
Independent Director7.1yrsUS$387.12k0%
€ 0
Steven James
Independent Director8.7yrsUS$387.12k0%
€ 0
Neil Graham
Independent Director1.3yrsUS$378.28k0%
€ 0
Amy Ladd
Independent Director2.4yrsUS$372.12k0%
€ 0
Robert Andreatta
Independent Director6.5yrsUS$389.62k0%
€ 0
Bruce Bochner
Member of Scientific Advisory Boardno datano datano data
Robert Schleimer
Member of Scientific Advisory Boardno datano datano data
Dolca Thomas
Independent Director1.4yrsUS$732.48k0.043%
€ 44.6k

6.5yrs

Average Tenure

62yo

Average Age

Experienced Board: 37Z's board of directors are considered experienced (6.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 01:43
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Allakos Inc. is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carter GouldBarclays
Jason ZemanskyBofA Global Research
Jennifer KimCantor Fitzgerald & Co.